Abstract Details
|
Haris Kamal, MD
(University of Texas At Houston)
PRESENTER |
Dr. Kamal has nothing to disclose. |
| Noureldin Abdelhamid, MD (Methodist Houston Hospital) | Dr. Abdelhamid has nothing to disclose. |
| James C. Grotta, MD, FAAN (Memorial Hermann Hospital Life Flight) | Dr. Grotta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Frazer Ltd. Dr. Grotta has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Haemonetics. Dr. Grotta has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acticor. Dr. Grotta has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prolong Pharma. Dr. Grotta has received publishing royalties from a publication relating to health care. Dr. Grotta has received publishing royalties from a publication relating to health care. |
| No disclosure on file | |
| Sean I. Savitz, MD | Dr. Savitz has nothing to disclose. |
| Amrou Sarraj, MD | Dr. Sarraj has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. Dr. Sarraj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker Neurovascular. Dr. Sarraj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Stryker Neurovascular. The institution of Dr. Sarraj has received research support from Stryker Neurovascular. |